References
Rapid haemostasis to achieve dressing longevity: evaluation trial results using StatSeal catheter exit site protection
Abstract
Peripherally inserted central catheters (PICCs) are vital in delivering intravenous therapy. Despite their advantages, PICCs can lead to complications such as catheter exit site bleeding, which can cause patient distress and increase infection risk. This study evaluated the efficacy of StatSeal, a topical haemostatic device, in managing PICC exit site bleeding. StatSeal uses a hydrophilic polymer and potassium ferrate to form a seal, reducing access site bleeding and minimising dressing changes. For this study, Patients were recruited at Frimley Health NHS Foundation Trust; the trial involved 177 patients with StatSeal, and shows that 99% did not require additional dressing changes within the standard 7-day period. The findings demonstrate StatSeal's effectiveness in improving patient outcomes by reducing exit site bleeding and associated complications, enhancing the efficiency of vascular access maintenance and potentially lowering associated healthcare costs. The trial emphasises the importance of innovative solutions such as StatSeal to advance PICC care and improve patient experience.
Since the 1970s, peripherally inserted central catheters (PICCs) have been used to deliver intravenous (IV) therapy, initially in critical care for patients requiring vasoactive medications, multiple infusions and frequent blood sampling and to reduce needlestick injury (Mielke, et al, 2020). As modern healthcare has adapted and responded to major changes in health trends, the benefits of using PICCs in delivering IV therapies have become well evidenced (Ray-Barruel, et al, 2022; Pinelli et al, 2023a).
PICCs are classified as long-term vascular access devices because they can remain in situ for as long as the patient requires IV access (Moss et al, 2021). They are used in hospital inpatients requiring vesicant medical treatments such as chemotherapy, antibiotic therapy and parenteral nutrition; they are also used to support early discharge from secondary care into alternative community care settings or the patient's home for ongoing IV therapy, commonly referred to as outpatient parenteral antibiotic therapy (Govindan et al, 2021; Clarkson and Snape, 2024).
Register now to continue reading
Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:
What's included
-
Limited access to clinical or professional articles
-
Unlimited access to the latest news, blogs and video content